These more sustainable additions to the Mevopur portfolio are being featured at Pharmapack Europe 2022, being held 18 and 19 May in the Paris Expo
'Using the new bio-based Mevopur polymer solutions instead of conventional materials,' says
Manufactured using non-fossil feedstocks, the new Mevopur concentrates include polymers with bio-based content between 70 and 100%, as calculated to ASTM D6866 standard. Along with pre-colored formulations for users who prefer ready-to-use solutions, they are more sustainable drop-in replacements for fossil-based materials. These bio-based materials can be processed on standard injection-molding machines and extruders and can be recycled in the same recycling channels as conventional fossil-based polymers.
Like other Mevopur formulations, they are produced in dedicated facilities according to ISO 13485-2016 protocols and supported by testing to ISO 10993-1, USP, European Pharmacopeia and ICH Q3D guidelines. Documented change control beyond CAS number is practiced and Registered Drug
About
Unique technologies that improve the recyclability of products and enable recycled content to be incorporated, thus advancing a more circular economy
Light-weighting solutions that replace heavier traditional materials like metal, glass and wood, which can improve fuel efficiency in all modes of transportation and reduce
Sustainable infrastructure solutions that increase energy efficiency, renewable energy, natural resource conservation and fiber optic / 5G network accessibility
To access
# # #
Media contact:
scollins@collins-marcom.com
+1 216.382.8840
(C) 2022 Electronic News Publishing, source